Conference Coverage: EHA 2024 – Focus on Multiple Myeloma

The latest therapeutic developments in multiple myeloma – how will they change our approach to treatment patterns?

June 15, 2024

Faculty Chair

Rafael Fonseca, MD

Mayo Clinic, Phoenix, AZ, USA

Faculty Members

Shaji Kumar, MD
Mayo Clinic, Rochester, MN, USA

Bruno Paiva, PharmD, PhD
Clinica Universidad de Navarra, Pamplona, Spain

Thierry Facon, MD
Lille University Hospital, Lille, France

Mohamad Mohty, MD, PhD
Sorbonne University, Paris, France

Hermann Einsele, MD, FRCP
University Hospital Würzburg, Germany

Evangelos Terpos, MD, PhD
National and Kapodistrian University of Athens, Greece

Sagar Lonial, MD, FACP
Winship Cancer Institute, Emory University, Atlanta, GA, USA

Agenda

Download the meeting agenda

View Agenda

REPORT TOPICS

  • Newly Diagnosed Multiple Myeloma: Transplant Eligible
  • Newly Diagnosed Multiple Myeloma: Transplant Ineligible
  • Relapsed/Refractory Multiple Myeloma: Small Molecules
  • Relapsed/Refractory Multiple Myeloma: Antibodies and Bispecifics I
  • Relapsed/Refractory Multiple Myeloma: Antibodies and Bispecifics II

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.